BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9448744)

  • 1. Characterization of central- and peripheral-type benzodiazepine receptors in rat salivary glands.
    Yamagishi H; Kawaguchi M
    Biochem Pharmacol; 1998 Jan; 55(2):209-14. PubMed ID: 9448744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of an 18-kDa protein associated with the peripheral-type benzodiazepine receptor in salivary glands.
    Yamagishi H; Watanabe M; Yazaki K; Sawaki K; Kawaguchi M
    Jpn J Pharmacol; 2000 Feb; 82(2):110-5. PubMed ID: 10877528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain.
    Rao VL; Butterworth RF
    Eur J Pharmacol; 1997 Dec; 340(1):89-99. PubMed ID: 9527511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo receptor labeling of peripheral benzodiazepine receptor by ex vivo binding of [3H]PK11195.
    Funakoshi T; Chaki S; Okuyama S; Okubo T; Nakazato A; Nagamine M; Tomisawa K
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):35-41. PubMed ID: 10850367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cofractionation of the 17-kD PK 14105 binding site protein with solubilized peripheral-type benzodiazepine binding sites.
    Mukhin AG; Zhong PY; Krueger KE
    Biochem Pharmacol; 1990 Sep; 40(5):983-9. PubMed ID: 2167683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunitrazepam photoaffinity labeling of the GABA(A) receptor reduces inhibition of [3H]Ro15-4513 binding by GABA.
    Borden LA; Gibbs TT
    Eur J Pharmacol; 1990 Jun; 188(6):391-7. PubMed ID: 2164940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a high-affinity peripheral-type benzodiazepine receptor in rabbit urinary bladder.
    Smyth RJ; Uhlman EJ; Ruggieri MR
    J Urol; 1994 Apr; 151(4):1102-6. PubMed ID: 8126801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of central and peripheral benzodiazepine binding sites in the human pineal gland.
    Suranyi-Cadotte B; Lal S; Nair NP; Lafaille F; Quirion R
    Life Sci; 1987 Apr; 40(15):1537-43. PubMed ID: 3031403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazepam and desmethyldiazepam differ in their affinities and efficacies at 'central' and 'peripheral' benzodiazepine receptors.
    Gobbi M; Barone D; Mennini T; Garattini S
    J Pharm Pharmacol; 1987 May; 39(5):388-91. PubMed ID: 2886589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites.
    Awad M; Gavish M
    J Neurochem; 1987 Nov; 49(5):1407-14. PubMed ID: 2822854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of two classes of benzodiazepine binding sites in Schistosoma mansoni.
    Noël F; Mendonça-Silva DL; Thibaut JP; Lopes DV
    Parasitology; 2007 Jul; 134(Pt 7):1003-12. PubMed ID: 17316476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine binding to GABAA receptors: differential effects of sulfhydryl modification.
    Duncalfe LL; Dunn SM
    Eur J Pharmacol; 1993 Jul; 246(2):141-8. PubMed ID: 8397093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the characteristics of low affinity GABA binding sites elicited by Ro15-1788.
    Concas A; Serra M; Crisponi G; Nurchi V; Corda MG; Biggio G
    Life Sci; 1985 Jan; 36(4):329-37. PubMed ID: 2981389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a high-affinity peripheral-type benzodiazepine binding site in rat aortic smooth muscle membranes.
    French JF; Matlib MA
    J Pharmacol Exp Ther; 1988 Oct; 247(1):23-8. PubMed ID: 2845053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.
    Lingford-Hughes A; Hume SP; Feeney A; Hirani E; Osman S; Cunningham VJ; Pike VW; Brooks DJ; Nutt DJ
    J Cereb Blood Flow Metab; 2002 Jul; 22(7):878-89. PubMed ID: 12142573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Peripheral type" benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization.
    Benavides J; Malgouris C; Imbault F; Begassat F; Uzan A; Renault C; Dubroeucq MC; Gueremy C; Le Fur G
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):38-49. PubMed ID: 6667063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ligand binding to mitochondrial benzodiazepine receptors.
    Hirsch JD; Beyer CF; Malkowitz L; Loullis CC; Blume AJ
    Mol Pharmacol; 1989 Jan; 35(1):164-72. PubMed ID: 2536464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine binding characteristics of embryonic rat brain neurons grown in culture.
    Syapin PJ; Cole R; De Vellis J; Noble EP
    J Neurochem; 1985 Dec; 45(6):1797-801. PubMed ID: 2997398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purines interact with 'central' but not 'peripheral' benzodiazepine binding sites.
    Skerritt JH; Chen Chow S; Johnston GA; Davies LP
    Neurosci Lett; 1982 Dec; 34(1):63-8. PubMed ID: 6298671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, RO5-4864, of the peripheral benzodiazepine receptors.
    Bénavidès J; Begassat F; Phan T; Tur C; Uzan A; Renault C; Dubroeucq MC; Guérémy C; Le Fur G
    Life Sci; 1984 Sep; 35(12):1249-56. PubMed ID: 6090832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.